Alto Neuroscience, Inc.

ANRO

US02157Q1094

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 12:54:14 2024-07-16 EDT			5-day change	1st Jan Change
15.6 ^USD	+7.55%		+18.17%	0.00%

01:30pm	Alto Neuroscience, Inc. Announces Enrollment Completion in Phase 2b Study of ALTO-100 in Major Depressive Disorder	CI
07-01	Alto Neuroscience, Inc.(NYSE:ANRO) added to Russell Small Cap Comp Value Index	CI

Alto Neuroscience, Inc.(NYSE:ANRO) added to Russell 3000 Index

July 30, 2024

Latest news about Alto Neuroscience, Inc.

Alto Neuroscience, Inc. Announces Enrollment Completion in Phase 2b Study of ALTO-100 in Major Depressive Disorder	07:30am	CI
Alto Neuroscience, Inc.(NYSE:ANRO) added to Russell Small Cap Comp Value Index	06-30	CI
Alto Neuroscience, Inc.(NYSE:ANRO) added to Russell Small Cap Completeness Index	06-30	CI
Alto Neuroscience, Inc.(NYSE:ANRO) added to Russell 2000 Value Index	06-30	CI
Alto Neuroscience, Inc.(NYSE:ANRO) added to Russell Microcap Growth Index	06-30	CI
Alto Neuroscience, Inc.(NYSE:ANRO) added to Russell 3000 Value Index	06-30	CI
Alto Neuroscience, Inc.(NYSE:ANRO) added to Russell 2000 Index	06-30	CI
Alto Neuroscience, Inc.(NYSE:ANRO) added to Russell 3000E Index	06-30	CI
Alto Neuroscience, Inc.(NYSE:ANRO) added to Russell 2500 Value Index	06-30	CI
Alto Neuroscience, Inc.(NYSE:ANRO) added to Russell Microcap Index	06-30	CI
Alto Neuroscience, Inc.(NYSE:ANRO) added to Russell 2500 Growth Index	06-30	CI
Alto Neuroscience, Inc.(NYSE:ANRO) added to Russell Small Cap Comp Growth Index	06-30	CI
Alto Neuroscience, Inc.(NYSE:ANRO) added to Russell 3000E Growth Index	06-30	CI
Alto Neuroscience, Inc.(NYSE:ANRO) added to Russell 3000 Growth Index	06-30	CI
Alto Neuroscience, Inc.(NYSE:ANRO) added to Russell 2000 Growth Index	06-30	CI
Alto Neuroscience, Inc.(NYSE:ANRO) added to Russell 2000 Dynamic Index	06-30	CI
Alto Neuroscience, Inc.(NYSE:ANRO) added to Russell Microcap Value Index	06-30	CI
Alto Neuroscience, Inc.(NYSE:ANRO) added to Russell 3000E Value Index	06-30	CI
Alto Neuroscience, Inc.(NYSE:ANRO) added to Russell 2500 Index	06-30	CI
Alto Neuroscience, Inc.(NYSE:ANRO) added to Russell 3000 Index	06-30	CI
Alto Neuroscience, Inc.(NYSE:ANRO) added to S&P Global BMI Index	06-23	CI
Alto Neuroscience, Inc. Initiates Phase 2 Study of ALTO-101, Novel PDE4 Inhibitor, in Cognitive Impairment Associated with Schizophrenia	06-20	CI
Alto Neuroscience, Inc. Appoints Michael Hanley as Chief Operating Officer	05-21	CI
Alto Neuroscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-14	CI
Alto Neuroscience, Inc. Announces Positive Phase 1 Results for ALTO-101, A Novel PDE4 Inhibitor in Development for Schizophrenia	04-23	CI

Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on redefining psychiatry by leveraging individualsâ neurobiology to develop personalized and effective treatment options. Through insights derived from the Companyâs scalable and proprietary Precision Psychiatry Platform, which applies rigorous data science and robust analytics to data gathered by neurocognitive assessments, electroencephalography, and wearable devices, the Company aims to discover brain-based biomarkers to better identify which patients are more likely to respond to its novel product candidates. Its pipeline consists of five clinical-stage assets, such as ALTO-100, ALTO-202, ALTO-300, ALTO-101, and ALTO-203, which target depressive disorder and schizophrenia populations as identified by independent brain-based biomarkers. Its pipeline also includes novel drug candidates in depression, post-traumatic stress disorder (PTSD), and other mental health conditions.

Sector

Biotechnology & Medical Research

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

14.5 USD

Average target price

32.09 USD

Spread / Average Target

+121.31%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
ALTO NEUROSCIENCE, INC.	0.00%	390M
MODERNA, INC.	+25.20%	46.56B
LONZA GROUP AG	+45.38%	41.67B
IQVIA HOLDINGS INC.	+0.25%	41.16B
ALNYLAM PHARMACEUTICALS, INC.	+33.52%	32.4B
ICON PUBLIC LIMITED COMPANY	+20.93%	28.18B
CELLTRION, INC.	-6.35%	28.1B
UNITED THERAPEUTICS CORPORATION	+49.20%	14.52B
MEDPACE HOLDINGS, INC.	+47.31%	13.74B
BIO-TECHNE CORPORATION	+3.16%	12.17B

Other Biotechnology & Medical Research